Maravai Lifesciences Holdings Inc (MRVI) — Capital Reinvestment Ratio
Maravai Lifesciences Holdings Inc (MRVI) has a Capital Reinvestment Ratio of 0.73x as of September 2024, meaning it reinvests 1% of its operating cash flow ($13.14 Million) in capital expenditures ($9.59 Million). See net asset quality index of Maravai Lifesciences Holdings Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Maravai Lifesciences Holdings Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Maravai Lifesciences Holdings Inc's Capital Reinvestment Ratio across 6 annual periods. Check Maravai Lifesciences Holdings Inc (MRVI) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Maravai Lifesciences Holdings Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Maravai Lifesciences Holdings Inc from 2019 to 2024. For live market cap and broader valuation context, see Maravai Lifesciences Holdings Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.97x | $7.46 Million | $29.66 Million | ▲ +665.0% |
| 2023 | 0.52x | $126.22 Million | $65.55 Million | ▲ +1528.8% |
| 2022 | 0.03x | $535.98 Million | $17.09 Million | ▼ -20.9% |
| 2021 | 0.04x | $368.57 Million | $14.85 Million | ▼ -75.9% |
| 2020 | 0.17x | $152.19 Million | $25.41 Million | ▼ -76.5% |
| 2019 | 0.71x | $24.11 Million | $17.15 Million | — |